Effect of acupoint massage on pain-fatigue-sleep disorder symptom group in postoperative chemotherapy patients with gastric cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069538

Enrollment

Unknown

Registered

2023-03-20

Start date

2023-03-20

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

control group:conventional treatment and care

intervention group:acupoint massage on the basis of conventional treatment and care

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria for gastric cancer; ?Aged 40~60 years old; ? After radical resection of gastric cancer (TNM stage II-III), those who plan to receive 6 cycles of postoperative adjuvant chemotherapy. The chemotherapy regimen was recommended according to the guidelines, oxaliplatin combined with capecitabine (XELOX), oxaliplatin combined with S-1 (SOX), oxaliplatin combined with fluorouracil (FLOFOX); ? Expected survival time is greater than 3 months; ? There are three symptoms of pain, fatigue, and sleep disturbance at the same time (the score of the Chinese version of the Brief Pain Scale is = 1 point, the score of the Chinese version of the Brief Fatigue Scale is = 1 point, and the Pittsburgh Sleep Quality Index score is > 7 points); ?Those with clear consciousness, good comprehension ability, and clear and complete expression; ? Those who have given informed consent and are willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: ?Pain, fatigue and sleep disturbance caused by other reasons; ? People with edema, redness, ulceration and other contraindications to massage; ? Patients with other serious organic diseases such as heart, liver and kidney; ? Have mental problems or have reported a history of mental disorders; ? Those who received radiotherapy and other anti-tumor treatments during postoperative chemotherapy; ? Those who are participating in other clinical trials that interfere with the evaluation of the results of this study.

Design outcomes

Primary

Measure	Time frame
pain level;fatigue level;Sleep quality;	—

Secondary

Measure	Time frame
quality of life;inflammation indicators;	—

Countries

China

Contacts

Public ContactYue Kong

900TH Hospital of Joint Logistics Support Force

xmky2005@126.com18850388138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026